Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.2K
Overview
44.2K
Conjugated Proteins02:50

Conjugated Proteins

18.2K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.2K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

14.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical site infection definitions consensus: a first step toward improving prevention in veterinary medicine.

American journal of veterinary research·2025
Same author

Equivalent reduction of Escherichia coli by rinsing hands with cold and warm water.

GMS hygiene and infection control·2025
Same author

Effect of Face Masking on Transmission of SARS-CoV-2.

Advances in experimental medicine and biology·2024
Same author

Evaluation of a microscale quantitative suspension test to determine the bactericidal and yeasticidal activity of glutaral - one step to improve sustainability in disinfectant testing.

GMS hygiene and infection control·2024
Same author

Acute lower respiratory tract infections have mainly become a secondary diagnosis in 2022 in hospitalized COVID-19 cases in Germany.

Infection·2023
Same author

Hospitalised Myocarditis and Pericarditis Cases in Germany Indicate a Higher Post-Vaccination Risk for Young People Mainly after COVID-19 Vaccination.

Journal of clinical medicine·2022

Related Experiment Video

Updated: Jun 13, 2025

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

1.6K

Does the COVID-19 Vaccination Reduce the Risk to Transmit SARS-CoV-2 to Others?

Günter Kampf1

  • 1University Medicine Greifswald, Ferdinand-Sauerbruch-Strasse, 17475, Greifswald, Germany. guenter.kampf@uni-greifswald.de.

Advances in Experimental Medicine and Biology
|September 16, 2024
PubMed
Summary

COVID-19 vaccination does not consistently lower viral load or significantly reduce SARS-CoV-2 transmission risk. Evidence suggests vaccinated individuals may not be less infectious to others, challenging prior assumptions.

Keywords:
COVID-19SARS-CoV-2TransmissionVaccinationViral load

More Related Videos

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.6K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.7K

Related Experiment Videos

Last Updated: Jun 13, 2025

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

1.6K
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.6K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.7K

Area of Science:

  • Virology
  • Epidemiology
  • Immunology

Background:

  • * COVID-19 vaccines were assumed to reduce virus transmission.
  • * Viral load and infectiousness are key factors in transmission dynamics.

Purpose of the Study:

  • * To evaluate the impact of COVID-19 vaccination on SARS-CoV-2 transmission.
  • * To assess viral load and infectiousness in vaccinated versus unvaccinated individuals.

Main Methods:

  • * Analysis of viral load data during different SARS-CoV-2 variant predominance periods (Delta, Omicron).
  • * Review of transmission studies examining secondary attack rates.
  • * Examination of public health data on case numbers and vaccination status.

Main Results:

  • * Viral loads in vaccinated individuals were not consistently lower than in unvaccinated during Delta; Omicron showed higher viral loads.
  • * Infectious SARS-CoV-2 levels were only partly lower in vaccinated populations.
  • * Secondary attack rates were influenced by the contact population's vaccination status, not solely the index case's.
  • * Real-world data indicate higher case numbers among vaccinated and boosted individuals.

Conclusions:

  • * Current evidence does not convincingly demonstrate that COVID-19 vaccination significantly reduces the risk of SARS-CoV-2 transmission.
  • * The assumption of reduced transmission due to vaccination requires further investigation, especially considering variant evolution.